In the same study, HbA1c levels were reduced by 1.1% to 1.4%
Neuropsychopharmacology 36 , 11711177 (2011)
Jonkers 2006
Lewis report using low-dose GLP-1s alongside therapy and lifestyle changes with meaningful results and minimal side effects for patients struggling with both obesity and mental health issues
The PLS-DA model yielded robust statistical parameters (R2 = 0.82, Q2 = 0.60), supporting its discriminative power
Medical Exclusions : You may not qualify if you have type 1 diabetes, chronic pancreatitis or medication-induced pancreatitis (GLP-1 related), severe gastrointestinal disease, current gallbladder problems (except post-removal), retinal impairment/diabetic retinopathy, recent bariatric surgery, multiple endocrine neoplasia syndrome type 2 (MEN2), or a history of medullary thyroid cancer